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1. Introduction
Performance bias refers to the conduct of a trial inadvertently
introducing differences between randomized groups other than
the intervention(s) being evaluated. Such departures from
intended study design may compromise study aims by under-
mining capacity to make valid inferences about intervention
effects. In healthcare contexts, staff provision of differential care
when there is a lack of blinding about randomization status
constitutes a classic example of this phenomenon. Indeed
differential care has been included within the deﬁnition offered
by the Cochrane Collaboration as ‘‘systematic differences between
groups in the care that is provided, or in exposure to factors other
than the interventions of interest’’ [1]. Whilst considered in the
context of systematic reviews [e.g. [2]] and related research
methods texts, it is not obvious that this construct has itself been
subjected to empirical research scrutiny.
Randomization is a somewhat unusual process as chance does
not overtly govern many decisions in people’s lives, and this may
provoke apprehension in advance or result in disappointment for
some trial participants [3]. Randomization is important in health
sciences and is widely used for good reasons, though paradoxically
its direct effects are rarely measured [4]. Placebo control conditions
are used in trials to manage the possible effects of disappointment,
as well as to take account of the placebo effect itself [5]. Due to
concerns such as these, patient preference designs have been
developed to avoid randomizing participants with strong allocation
preferences to study conditions that would be disappointing [6].
Some systematic reviews have identiﬁed capacity of preferences to
impact on trial outcomes [7] whereas others have not [8].
Zelen designs have also been developed for situations where
seeking consent to be randomized may be problematic [9].
Systematic reviews provide evidence of the use of Zelen and
patient preference designs in many areas [8,10], which might
suggest that the underlying problems associated with disappoint-
ment, and their implications, are well understood.
There have been valuable studies of public understanding of
various aspects of randomization [11,12]. Qualitative studies have
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identiﬁed preferences to be potentially complex and dynamic, as
well as being amenable to dedicated interventions [13]. How
information about randomization is presented in seeking informed
consent has received scrutiny [14] and dedicated interventions
have successfully enhanced informed consent and recruitment to
trials [15]. There are also qualitative studies investigating whether
and how trial participants react to being randomized [16], though
most such studies have been undertaken in clinical contexts where
contextual effects may be pronounced, such as neo-natal intensive
care units [17].
Cook and Campbell [3] have suggested possible responses to
disappointment, ranging from control group participants trying
harder by accessing interventions outside trials (termed ‘‘com-
pensatory rivalry’’) to participants giving up as a result of
disappointment (‘‘resentful demoralization’’). Without control of
such reactions, trials may be vulnerable to performance bias (1).
One leading trialist [18] has gone as far as to suggest that ‘‘the next
substantive milestone in the history of efforts to create unbiased
comparison groups may be erected when someone solves the
interesting methodological conundrum presented by biases
resulting from patient preferences’’.
Randomized controlled trials, like other research studies,
involve interactions between participants and researchers. Patient
preferences may have implications for the actual conduct of these
studies, although trial design seeks to preclude this possibility,
along with any impact on trial outcomes. This preliminary
investigation explores how patient preferences may be associated
with performance bias in one trial by examining reasons for
participation and participant engagement with the research study.
In so doing, it seeks to offer a participant-centered view of what it is
like to become involved in a trial, in order to better appreciate the
potential for biases that stem from research participation itself,
which may not be well understood [19].
2. Methods
Case studies are investigations which pay particular attention
to the contexts in which data are produced [20]. This is a case
study particularly concerned with patient preferences and
possible performance bias in the CAMWEL (Camden Weight
Loss) trial evaluating a patient counseling intervention delivered
in primary care to help people lose weight in comparison with
usual care [21]. We thus emphasize the patient counseling
evaluation study context and the intrinsically unblinded nature
of this contrast, where usual care was familiar to participants.
Lifestyle interventions in the primary care setting are widely
recognized as being important for public health purposes, so such
studies must be as rigorous as possible [22]. A brief trial
description is provided below, with further details available
elsewhere [21].
The CAMWEL trial evaluated the effectiveness of a structured
one-to-one support program delivered in primary care over a 12
month period by trained advisors for overweight or obese people
who wished to lose weight among residents of Camden, an
ethnically diverse inner London borough with a mix of areas of
relative afﬂuence and deprivation. The trial participants were 381
adults with body mass index (BMI)  25 kg/m2 recruited in 23/39
National Health Service (NHS) Camden general practices between
July 2009 and January 2010 [21]. The trial was pragmatic in nature
so as to be generalizable across the UK NHS, with as few exclusion
criteria as possible [21]. Brief telephone screening was followed
by a face-to-face appointment with a researcher for informed
consent, baseline questionnaire completion and anthropometric
measures. Participants were randomly allocated to the patient
counseling program being evaluated or to usual care, which
is general practitioner management, potentially involving
prescription of weight loss drugs, referral to dieticians or for
weight loss surgery [21].
Process studies are recommended within trials to conﬁrm
that the study is being implemented as intended and to explore
intervention delivery issues, contextual factors and possible
mechanisms linking processes to outcomes [23]. The CAMWEL
process study collected semi-structured  interview data from
34 (17 in each arm) of the 381 trial participants who were
purposively selected to be diverse in gender, age, education
and baseline weight. Participants provided separate consent to
take part in the process study. The trial was approved by the
London School of Hygiene & Tropical Medicine (LSHTM) Ethics
Committee, the Camden and Islington Community Research
Ethics Committee (REC Reference number 09/H0722/22), and
the North Central London Research Consortium.
The purpose of this study is to explore to what extent
participants’ reactions to being randomized, in the context of their
decision to take part in the trial, inform understanding of the
construct of performance bias. During the ﬁrst process study
interview, undertaken usually in the weeks following communica-
tion of the outcome of randomization by telephone, we investigated
what impact the conduct of the trial had on 14 consecutive process
study participants (8 control group, 6 intervention group). The data
presented here in this preliminary investigation are participants’
responses to a small number of dedicated questions about the
process of study participation in a 30-min interview, primarily
undertaken for other purposes. Participants were invited to recall
how they found out about the study and were asked for example,
‘‘what was your main reason for taking part’’ and ‘‘what were your
hopes for taking part in the study’’. This invitation extended
chronologically to all their early contacts up to and including
randomization with invitations such as ‘‘If you could just think
back to the screening visit. . .what do you remember’’. Participants
thus recounted their experiences and answered questions such as
‘‘after you came out of the screening visit, did you think anything
differently about your weight?’’ and after communication of
allocation, ‘‘how did you feel about that?’’ The data were not
collected in an inductive manner, with each interview being
informed by the previous interviews; rather, the same topic guide
was used for all interviewees. All interviews were conducted by
the second author, digitally recorded and later transcribed. Most
took place in the GP practice where the participant had been
assessed, with some also on the premises of LSHTM or via
telephone, at the convenience of the participant.
Data relating to patient preferences (mostly made up of the
responses to the dedicated questions) were retrieved and
examined independently by JM and AS. Each drafted a coding
frame, after which a consensus meeting was held to agree on the
ﬁnal set of codes, which the ﬁrst author applied to the dataset
using word processing software. A thematic content analysis of
these data was undertaken, which focused on latent rather than
manifest patterns of meaning [24]. The coding and analysis is best
described as primarily deductive in that it was led by author JM
who looked for concepts previously described in relevant
literature. That noted, both analysts were open to types of
research participation effects that had not previously been
identiﬁed, as is reﬂected in the Results below. With assistance
at the writing-up stage from author AQ, an experienced qualitative
analyst, themes that were not substantial enough were excluded
from the report, i.e. where the data were insufﬁcient to reach
theoretical saturation. Data from individual participants are
presented by participant number, with the group to which they
belonged indicated by Intervention Group [IG] or Control Group
[CG] as appropriate. To shorten quotes and make them easier to
read, parts of the utterance have been omitted. These are
represented by bracketed ellipsis: [. . .].
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3. Results
We present data on reasons for participation, prior to
examining the reactions of the control group and the intervention
group to their allocation. The concepts of ‘conditional’ or ‘weak’
altruism have been developed to describe reasons for participation
that beneﬁt both the individual concerned and wider society
[25,26]. There was some evidence for this in our sample:
I got this circular which said they were looking for volunteers
and I thought ‘well it might be helpful to me as well as helpful to
someone else’. (Participant 3 [IG])
However, the invitation to participate in the trial was much more
commonly perceived as a ‘‘helping hand’’ and an opportunity to
access new forms of help:
Actually, it was more of a helping hand. You know what I mean?
It was someone come and help me. So that’s why I replied
almost straight away, like, you know, so when I got home that
night I was ‘let’s have a go at this, see what this brings’
(Participant 14 [IG])
I was thinking about doing something about [losing weight] but
I didn’t know how. (Participant 8 [IG])
Well I was hopeful, maybe, there would be something new, if it
would help me lose weight, you know, or something better than
what I’ve tried before because the things I’ve done before don’t
work very well. (Participant 2 [CG])
Others perceived it as an opportunity to learn how to manage their
weight better:
I thought that with this studies thing that maybe it would help
me to understand how best maybe for me to go with my weight
management. (Participant 4 [IG]))
What it made me think was, you know, that my GP was
obviously taking my concerns quite seriously and he’s trying to
help me (Participant 12 [CG])
This study shows the obvious potential for conﬂict between
seeking new forms of help as a reason for participation and the
possibility of being allocated to a familiar usual care control group
in which no new help is provided. This situation contrasts with
other trials in which people may prefer allocation to standard
practice as compared to innovations that are untested [27].
Participants generally appreciated the uncertainty involved in
random allocation, if not the technical details, though the
possibility that they might not get the novel intervention was
not always prominent in the accounts provided. One participant
spoke of her disappointment at having not been put in the ‘‘favored
group’’:
I suppose truthfully, [I was] a bit disappointed, but not for long
because it’s a research project. I just would have liked to have
been in what I then considered the favored group! Of course
because, you know, I think that that will work better for people
and I presume that is the hypothesis. (Participant 10 [CG])
The strength of disappointment expressed by control participants
varied widely. One spoke of being ‘‘a bit miffed’’ (a colloquial term
for strong disappointment):
The only thing I was disappointed about was because I did not
actually get the [arm of the] trial I wanted [. . .] That’s where I
was, kind of, really a bit miffed because I really, really wanted to
do that program ‘cos I thought that program was good for me,
but it did not happen. (Participant 13 [CG])
For another, allocation to the control group had left her feeling
‘‘totally disgusted’’ because it had meant that ‘‘nobody wants to
help me’’:
The truth? Totally disgusted. ‘Cos I thought I was going to get
some help and nobody wants to help me. You know, and I have
put on weight since the last time I came, I know I have. I feel it in
my body and the scales say I have. And I just want someone to
help me. (Participant 6 [CG])
This appears a good example of resentful demoralization. Another
control group participant drew on pre-existing knowledge of
science to rationalize acceptance of their allocation:
Well I understand science so I know there has to be a sample
group that is not participating, as a control group. So I knew that
I could possibly get into the control group which I did, so I just
accepted that. [. . .] I was kind of disappointed because I was
hoping for something different, instead I do not have anything
at all really. (Participant 2 [CG])
Awareness of the trial context aroused curiosity in one participant:
I’ve gone to see my GP, that’s sort of prompted me to ask him, I
was just more curious [. . .] The point was, I kind of went to see
him out of, purely [. . .] knowing there was a trial in place so I
knew there were two programs, so it sort of spurred me on to,
sort of, see what they would offer. (Participant 5 [CG])
Allocation to the control group was perceived by another
participant to have not given them ‘‘more of an incentive’’ to lose
weight:
You think of something like this as giving you more of an
incentive except that so far it hasn’t [. . .]. It’s like it’s doing some
kind of an experiment, which we do not really know what it is.
(Participant 1 [CG])
There was some evidence for compensatory rivalry [3] in our
sample, but of a type not previously described in the literature:
Well, I do not think I have any particular hopes actually since I
was assigned to the control group, as it were. I think I’ve decided
to take my own control again. (Participant 10 [CG])
What is novel here is the comment ‘‘I think I’ve decided to take my
own control’’, which implies a decision on the participant’s part to
change their behavior themselves, rather than necessarily seeking
alternative interventions outside the trial. Such a response may be
speciﬁc to trials where change in behavior can be achieved without
the aid of external resources.
Seven of the 8 control group participants expressed disap-
pointment, whereas all participants in the intervention group were
satisﬁed with their allocation. In some cases, they were simply
pleased to be receiving some additional support, as usual care was
seen as insufﬁcient.
I think I was more pleased because I know that GPs are
extremely busy, they hardly have time to talk to you, or hear
what you’re saying. (Participant 8 [IG])
I think I’d be faintly disappointed if I was, you know ‘you’re the
placebo control group, you just carry on!’(Participant 11 [IG])
Others hoped to be provided with ‘‘expert help’’.
I just feel that, in the intervention group, maybe there’ll be some
kind of other help rather than just the GP. I’m not saying that
going to the GP was a waste of time ‘cos it wasn’t ‘cos I then
went to their nutritionist and she went through my diet sheet
and stuff with me. I’m just happy that I am in the intervention
group ‘cos I’m hoping, now, that there’ll be some kind of expert
help for me. (Participant 4, IG)
4. Discussion and conclusion
4.1. Discussion
This study explored how patient preferences may be associated
with performance bias in CAMWEL by examining reasons for
participation which involve preferences and how participants
react to disappointment when their preferences are thwarted.
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Participants were disappointed at being randomized to usual care
because preference for the intervention arm was the principal
reason for participation. While they had not been apprehensive
about the use of chance as an allocation mechanism, their
reactions to being randomized to usual care ranged from being
‘‘spurred on’’ to explore usual care (Participant 5) and deciding to
assert ‘‘own control’’ (Participant 10) to being ‘‘totally disgusted’’
(Participant 6) at not being offered additional help. The reactions
captured here include those speculated about by Cook and
Campbell (3) more than 30 years ago. Whilst there is a
longstanding literature on reasons for participation in research,
there is not a body of work on how reasons for participation may
impact on trial outcomes. Patient preferences may impact on trial
outcomes [7,8], and this study contributes a new understanding of
some mechanisms by which this may occur. These issues are not
speciﬁc to patient counseling or behavioral intervention trials
[28].
Historically, altruism has been seen as the key motivation for all
forms of research participation [25,26], so it is striking how small a
role altruism seemed to have played in people’s decisions to
participate in this trial. The speciﬁc circumstances of evaluating
new methods of helping people change well established behaviors,
particularly where there have been past attempts to change, may
militate against altruism. Where conditional altruism was
reported, altruistic reasons appeared much weaker than the
primary motivation of help-seeking. Attempts made by some
participants to be good subjects were accompanied by uncertain-
ties about their roles and what was expected of them.
The reasons for participation articulated here appear prima facie
to have clear implications for how participants respond to their
allocated study condition. The lack of ﬁt between reasons for
participation (to access to new forms of help) and the content of
the control condition (usual care) explains the thwarted preference
and disappointment in this trial, but not participants’ reactions to
their disappointment. This is important in relation to possible
performance bias, which is concerned with unintended aspects of
the conduct of the study. The origins of the reactions captured here
lie implicitly within the design of the trial itself, where there is
potential for conﬂict between reasons for participation which
involve preferences and the outcome of randomization.
It is a moot point whether performance bias is the most
appropriate conceptualization of this problem, yet these reactions
do deserve to be recognized as a distinct source of bias. This is
because they lead the randomized groups to differ in ways other
than the intended experimental contrast. It may be that a
conceptualization is needed that distinguishes unintended differ-
ences between groups in how participants are treated in the
conduct of the trial (performance bias) from systematically
different reactions between randomized groups to identical trial
procedures. A different deﬁnition of performance bias that is not
restricted to how participants are treated by the study may be
useful, and more ﬁne grained attention to how participants react to
what they are asked to do in research, and how this may impact on
study outcomes, is needed.
The possible direction and magnitude of bias is important to
consider. In this trial, there was some evidence of small differences
in outcomes, though not in the primary outcome of weight loss
[21]. Inferences about effectiveness in studies which ﬁnd
differences between groups must take account of the possibility
that the types of reactions described here may be responsible for
some of these differences if it seems possible or likely that
disappointment may be involved. Compensatory rivalry responses
to the outcome of randomization may attenuate differences
between groups and resentful demoralization may exaggerate
them, so the former are particularly worth considering where there
are null ﬁndings. In this study, we saw evidence of both, and there
is thus no strong evidence that trial ﬁndings are systematically
biased in this instance.
Usual care or standard practice is a very common control
condition. Indeed, it is the standard against which innovations
should be assessed for ethical as well as methodological reasons,
hence its incorporation into the Helsinki Declaration [29]. In this
trial, and in many other evaluations of patient counseling in which
comparisons are made with usual care, blinding the participant to
their group allocation was impossible because usual care was
familiar and the novel intervention being evaluated obviously
distinct. Although unlikely for chronic conditions as seen here,
blinding allocation to usual care remains possible in circumstances
where usual care has not previously been received.
There are clear limitations to the present study where our
ﬁndings are based on relatively brief enquiries nested within
interviews with a small number of trial participants about
psychological and behavioral processes which are both long
running and complex. This study should thus be considered as
hypothesis generating for methodological investigations, revealing
possible mechanisms for the introduction of bias. We draw
attention to the need to better conceptualize and study how
reasons for participation may imply preferences in trials, and
possible mechanisms for the introduction of bias speciﬁcally
induced by disappointment due to thwarted allocation prefer-
ences. More generally, we should address how motivational and
other factors associated with research participation itself, includ-
ing speciﬁc roles or activities required of participants, may bias
study outcomes and thus undermine study aims, both for trials and
other study designs [30–34].
4.2. Conclusions
Efforts to access a novel counseling intervention within a
trial, when there have been prior attempts at weight loss,
resulted in satisfaction if successful, and disappointment if
unsuccessful. There is a prima facie case that reactions to
disappointment may introduce bias, as they lead the randomized
groups to differ in ways other than the intended experimental
contrast. There is a need to better identify disjunctures between
reasons for participation and the content of allocated study
conditions in trials. It is possible that there is widespread bias in
trials where there are such disjunctures. There is a clear need to
discover where this overlooked threat to valid inference in trials
is most acute and also whether our understanding of perfor-
mance bias provides the best guide to empirical study of these
issues.
4.3. Practice implications
This study has implications for trialists and not directly for
clinical practice. There is a widespread tendency within the
research community to view research procedures as inert [35]
and not inﬂuencing participant cognitions, emotions and
behavior. This was clearly not true for the participants in this
trial. Invitations to participate  in trials and subsequent study
requirements may interact in complex ways with people’s
ongoing struggles to lose weight. Having such a dynamic
conceptualization suggests the need for in-depth qualitative
longitudinal investigations nested within trials of participant
experiences. This study has obvious implications for the design of
trials with usual care control conditions which are unblinded for
participants, where participants prefer to avoid being allocated
to these study conditions. Preferences should be assessed and
alterations to conventional trial designs, such as patient
preference designs, should be considered where strong prefer-
ences appear likely.
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